Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes

Immunology Letters

Volumn 98, Issue 2, 2005, Pages 208-215

  Nugent, C Thomas ^a   Renteria, Roberto O ^a   Kuus Reichel, Kristine ^a   Kumar, Abhay ^a  

^a BECKMAN COULTER INC   (United States)

Author keywords

CD8+ T lymphocytes; Multimers; TCR avidity; Tetramers

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HEAVY CHAIN; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 18044382130     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.11.016     Document Type: Article

References (36)

1. J.D. Altman, P.A. Moss, P.J. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis Phenotypic analysis of antigen-specific T lymphocytes Science 274 1996 94 96
2. G.T. Nepom MHC multimers: expanding the clinical toolkit Clin Immunol 106 2003 1 4
3. P. Klenerman, V. Cerundolo, and P.R. Dunbar Tracking T cells with tetramers: new tales from new tools Nature Rev Immunol 2 2002 263 272
4. C.A. Janeway The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation Annu Rev Immunol 10 1992 645 674
5. M. Bodinier, M.-A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, and F. Lang Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding Nat Med 6 2000 707 710
6. R.D. Salter, R.J. Benjamin, P.K. Wesley, S.E. Buxton, T.P. Garrett, C. Clayberger, A.M. Krensky, A.M. Norment, D.R. Littman, and P. Parham A binding site for the T cell co-receptor CD8 on the alpha 3 domain of HLA-A2 Nature 345 1990 41 46
7. R.D. Salter, A.M. Norment, B.P. Chen, C. Clayberger, A.M. Krensky, D.R. Littman, and P. Parham Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8 Nature 338 1989 345 347
8. G.F. Gao, B.E. Willcox, J.R. Wyer, J.M. Boulter, C.A. Callaghan, K. Maenaka, D.I. Stuart, E.Y. Jones, J.I. van d Bell, and B.K. Jakobsen Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 alpha J Biol Chem 275 2000 15232 15238
9. V. Dutoit, P. Guillaume, M. Ayyoub, C.S. Hesdorffer, I.F. Luescher, and D. Valmori Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate J Immunol 170 2003 5110 5117
10. J.M. Connolly, T.H. Hansen, A.L. Ingold, and T.A. Potter Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T cell receptor recognize the same class I molecule Proc Natl Acad Sci USA 87 1990 2137 2141
11. T.A. Potter, J.A. Bluestone, and T.V. Rajan A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL J Exp Med 166 1987 956 966
12. M.A. Purbhoo, J.M. Boulter, D.A. Price, A.-L. Vuidepot, C.S. Hourigan, P.R. Dunbar, K. Olson, S.J. Dawson, R.E. Phillips, B.K. Jakobsen, J.I. Bell, and R. Sewell Ak The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor sigma chain J Biol Chem 276 2001 32786 32792
13. E.M.-L. Choi, J. Chen, L. Wooldridge, M. Salio, A. Lissina, N. Lissin, I.F. Hermans, J.D. Silk, F. Mirza, M.J. Palmowski, P.R. Dunbar, B.K. Jakobsen, A.K. Sewell, and V. Cerundolo High avidity antigen-specific CTL identified by CD8-independent tetramer staining J Immunol 171 2003 5116 5123
14. T.A. Potter, T.V. Rajan, R.F. Dick, and J.A. Bluestone Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes Nature 337 1989 73 75
15. F.R. Carbone, and M.J. Bevan Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization J Exp Med 169 1989 603 612
16. K.A. Hogquist, S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone T cell receptor antagonist peptides induce positive selection Cell 76 1994 17 27
17. H. Pircher, K. Burki, R. Lang, H. Hengartner, and R.M. Zinkernagel Tolerance induction in double specific T cell receptor transgenic mice varies with antigen Nature 342 1989 559 561
18. K. Falk, O. Rotzschke, S. Stevanoviç, G. Jung, and H.G. Rammensee Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules Nature 351 1991 290 296
19. A. Sette, A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W.M. Kast, C.J. Melief, C. Oseroff, L. Yuan, and J. Ruppert The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes J Immunol 153 1994 5586 5592
20. F. Letourneur, and B. Malissen Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin Eur J Immunol 19 1989 2269 2274
21. M.J. Pittet, V. Rubio-Godoy, G. Bioley, P. Guillaume, P. Batard, D. Speiser, I. Luescher, J. Cerottini, P. Romero, and A. Zippelius Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells J Immunol 171 2003 1844 1849
22. M.A. Alexander-Miller, G.R. Leggatt, and J.A. Berzofsky Selective expansion of high or low avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy Proc Natl Acad Sci USA 93 1996 4102 4107
23. G.M. Van Bleek, and S.G. Nathenson Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule Nature 348 1990 213 216
24. W.M. Kast, L. Roux, J. Curren, H.J. Blom, A.C. Voordouw, R.H. Meloen, D. Kolakofsky, and C.J. Melief Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide Proc Natl Acad Sci USA 88 1991 2283 2287
25. T.N. Schumacher, M.L. De Bruijn, L.N. Vernie, W.M. Kast, C.J. Melief, J.J. Neefjes, and H.L. Ploegh Peptide selection by MHC class I molecules Nature 350 1991 703 706
26. K.L. Rock, L. Rothstein, and S. Gamble Generation of class I MHC-restricted T-T hybridomas J Immunol 145 3 1990 804 811
27. A.M. Carbone, P. Marrack, and J.W. Kappler Remethylation at sites 5′ of the murine Lyt-2 gene in association with shutdown of Lyt-2 expression J Immunol 141 4 1988 1369 1375
28. E. Schott, and H.L. Ploegh Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells Eur J Immunol 32 2002 3425 3434
29. S.E. Kerry, J. Buslepp, L.A. Cramer, R. Maile, L.L. Hensley, A.I. Nielsen, P. Kavathas, B.J. Vilen, E.J. Collins, and J.A. Frelinger Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement J Immunol 171 2003 4493 4503
30. L. Wooldridge, S.L. Hutchinson, E.M. Choi, A. Lissina, E. Jones, F. Mirza, P.R. Dunbar, D.A. Price, V. Cerundolo, and A.K. Sewell Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface J Immunol 171 2003 6650 6660
31. L. Shen, T.A. Potter, and K.P. Kane Glu227→Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions J Exp Med 184 1996 1671 1683
32. S.L. Hutchinson, L. Wooldridge, S. Tafuro, B. Laugel, M. Glick, J.M. Boulter, B.K. Jakobsen, D.A. Price, and A.K. Sewell The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities J Biol Chem 278 2003 24285 24293
33. S. Valitutti, S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia Serial triggering of many T cell receptors by a few peptide-MHC complexes Nature 375 1995 148 151
34. + CTL clones is determined by the frequency of serial TCR engagement J Immunol 161 1998 553 562
35. M.A. Purbhoo, D.J. Irvine, J.B. Huppa, and M.M. Davis T cell killing does not require the formation of a stable mature immunological synapse Nat Immunol 5 2004 524 530
36. S.M. Alam, G.M. Davies, C.M. Lin, T. Zal, W. Nasholds, S.C. Jameson, K.A. Hogquist, N.R.J. Gascoigne, and P.J. Travers Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands Immunity 10 1999 227 237